This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Ocular Hypertension or Open Angle Glaucoma
and you are
between 18 and 99
years old
Phase
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Double-masked, randomized, multi-center, dose-response, active-controlled parallel-comparison of Netarsudil (AR-13324) to latanoprost

Provided treatments

  • Drug: AR-13324 Ophthalmic Solution 0.01%
  • Drug: AR-13324 Ophthalmic Solution 0.02%
  • Drug: Latanoprost ophthalmic solution 0.005%
Tris trial is registered with FDA with number: NCT01731002. The sponsor of the trial is Aerie Pharmaceuticals and it is looking for 224 volunteers for the current phase.
Official trial title:
A Phase 2 Study Comparing the Safety and Ocular Hypotensive Efficacy of Netarsudil (AR-13324) to Latanoprost in Patients With Elevated Intraocular Pressure